Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1484]

Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of cholangiocarcinoma patients

Matched targeted treatment based on ESCAT actionable genomic alterations associates with improved prognosis of...

Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen

Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen

New findings may contribute to better diagnosis and treatment of liver cancer

New findings may contribute to better diagnosis and treatment of liver cancer

Researchers identify signalling mechanisms in pancreatic cancer cells that could provide treatment targets

Researchers identify signalling mechanisms in pancreatic cancer cells that could provide treatment targets

Study reveals cancer's mechanism of resistance to PARP inhibitors

Study reveals cancer's mechanism of resistance to PARP inhibitors

New study in primary liver cancer calls for novel strategies targeting a dynamic landscape of heterogeneous tumours

New study in primary liver cancer calls for novel strategies targeting a dynamic landscape of heterogeneous tumours

CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy

CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy

New study sheds light on how fatty liver disease turns into liver cancer

New study sheds light on how fatty liver disease turns into liver cancer

Researchers find an explanation of why pancreatic cancer cells are so aggressive

Researchers find an explanation of why pancreatic cancer cells are so aggressive

Antiviral treatment for hepatitis C virus reduces risk of post-treatment liver cancer progression, study shows

Antiviral treatment for hepatitis C virus reduces risk of post-treatment liver cancer progression, study shows

More from ecancer